Oxford Biomedica is an innovative leading viral vector specialist focused on delivering life-changing therapies to patients. They offer end-to-end capabilities, from plasmid design and optimization to clinical and commercial CGMP manufacturing, ensuring high standards in the provision of therapeutic solutions within the pharmaceutical industry.

Services include:
- Cell and Gene Therapy
- Regulatory Services
- Protein and Peptide
- Viral Vector Development
- Analytical and Quality Control Services
- Clinical Trial Material Manufacturing

Oxford Biomedica plays a critical role in advancing the landscape of biopharmaceuticals and is committed to providing comprehensive support to its partners. For more information, please visit oxb.com.